Subscribe to
our newsletters

Subscribe to our newsletters!

Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.

Search in Nordic Life Science Insight

-
February 12, 2021
XVIVO Perfusion AB

Therapeutic Intervention During EVLP – Webinar March 3rd

Therapeutic Intervention During EVLP – Webinar March 3rd

We would like to invite you to our webinar on “Therapeutic Interventions during EVLP”.

Following the presentations there will be a Q&A session. And to summarize the event there will also be a panel discussion moderated by Prof. Göran Dellgren from Sahlgrenska University Hospital, Gothenburg Sweden.

Speakers for this webinar session is:

Ilker Iskender M.D – UZ Leuven, Leuven (BE)

Julien De Wolf M.D. – Hôpital Paris, Paris (FR)

Prof. John Fraser – The Prince Charles Hospital, Brisbane (AU)

The topics that will be covered during this webinar include:

  • New perspectives on ​​​​​​​​​​​​​​EVLP as a therapeutic platform
  • EVLP – A tool for interventional work with dialysis
  • Administration of endothelin receptor blocker during EVLP could improve pulmonary gas exchange
  • Can cytokine adsorbtion during EVLP improve post-transplant outcome

Register to the webinar by clicking on the REGISTER WEBINAR MARCH 3, 2021 on the blue bar.

Some of this content include off-label use of XVIVO’s technology.

Last updated:
February 12, 2021

XVIVO Perfusion AB

XVIVO Perfusion is a medical technology company focused on developing optimized solutions for organ, tissue and cell preservation in connection with transplantation.

Click here to read more about us!

We would like to invite you to our webinar on “Therapeutic Interventions during EVLP”.

Following the presentations there will be a Q&A session. And to summarize the event there will also be a panel discussion moderated by Prof. Göran Dellgren from Sahlgrenska University Hospital, Gothenburg Sweden.

Speakers for this webinar session is:

Ilker Iskender M.D – UZ Leuven, Leuven (BE)

Julien De Wolf M.D. – Hôpital Paris, Paris (FR)

Prof. John Fraser – The Prince Charles Hospital, Brisbane (AU)

The topics that will be covered during this webinar include:

  • New perspectives on ​​​​​​​​​​​​​​EVLP as a therapeutic platform
  • EVLP – A tool for interventional work with dialysis
  • Administration of endothelin receptor blocker during EVLP could improve pulmonary gas exchange
  • Can cytokine adsorbtion during EVLP improve post-transplant outcome

Register to the webinar by clicking on the REGISTER WEBINAR MARCH 3, 2021 on the blue bar.

Some of this content include off-label use of XVIVO’s technology.

Last updated:
February 12, 2021

XVIVO Perfusion AB

XVIVO Perfusion is a medical technology company focused on developing optimized solutions for organ, tissue and cell preservation in connection with transplantation.

Click here to read more about us!